Publicaciones (19) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research

  2. Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)

    Scientific Reports

  3. Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)

    Nature Medicine

  4. Comment on “Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3”

    Journal of Hepatology

  5. Comparison of symptomatic and asymptomatic infections due to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in San Francisco long-Term care facilities

    Infection Control and Hospital Epidemiology

  6. Corrigendum to: NMF-RI: blind spectral unmixing of highly mixed multispectral flow and image cytometry data

    Bioinformatics (Oxford, England)

  7. DNA-damaging cancer cells to improve virotherapy

    Molecular Therapy - Oncolytics

  8. Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives

    Frontiers in Immunology

  9. Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response

    Frontiers in Immunology

  10. Erratum: NMF-RI: blind spectral unmixing of highly mixed multispectral flow and image cytometry data (Bioinformatics (2020) DOI: 10.1093/bioinformatics/btz751)

    Bioinformatics

  11. HIF2α Activation in NASH: A New Force Pushing Toward HCC

    Cellular and Molecular Gastroenterology and Hepatology

  12. Hepatic progenitor cells, senescence and IL-6 as the main players in combined hepatocellular-cholangiocarcinoma development

    Journal of Hepatology

  13. Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinoma

    Journal of hepatology

  14. Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: Cui bono ?

    Gut

  15. Immunotherapy in HCC—No rush despite the hype

    Hepatology

  16. Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts

    American Journal of Hematology

  17. Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

    Journal of Hepatology

  18. The deleterious effect of acetaminophen in cancer immunotherapy

    Annals of Oncology

  19. Vulvar tumor in an infant

    Pediatric Dermatology